Trial Profile
Safety and efficacy of combination therapy of daclatasvir and asunaprevir in cirrhotic and non-cirrhotic patients with genotype 1b HCV
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Dec 2016
Price :
$35
*
At a glance
- Drugs Asunaprevir (Primary) ; Daclatasvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 21 Dec 2016 New trial record